SignatureFD’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
70,023
+4,329
+7% +$76K 0.02% 329
2025
Q4
$1.02M Sell
65,694
-15,089
-19% -$216K 0.02% 370
2025
Q3
$1.18M Buy
80,783
+1,152
+1% +$17.1K 0.02% 339
2025
Q2
$1.23M Buy
79,631
+12,052
+18% +$178K 0.02% 308
2025
Q1
$1M Buy
67,579
+2,482
+4% +$34.8K 0.02% 343
2024
Q4
$862K Buy
65,097
+19,786
+44% +$272K 0.02% 374
2024
Q3
$644K Buy
45,311
+10,070
+29% +$143K 0.01% 447
2024
Q2
$456K Sell
35,241
-14,900
-30% -$197K 0.01% 526
2024
Q1
$696K Buy
50,141
+10,654
+27% +$155K 0.01% 416
2023
Q4
$563K Sell
39,487
-3,838
-9% -$54.5K 0.01% 441
2023
Q3
$670K Sell
43,325
-351
-0.8% -$5.43K 0.02% 355
2023
Q2
$686K Buy
43,676
+523
+1% +$8.57K 0.02% 349
2023
Q1
$711K Buy
43,153
+14,538
+51% +$232K 0.02% 325
2022
Q4
$446K Sell
28,615
-6,688
-19% -$93.4K 0.01% 444
2022
Q3
$458K Buy
35,303
+10,972
+45% +$153K 0.02% 403
2022
Q2
$342K Sell
24,331
-10,720
-31% -$153K 0.01% 488
2022
Q1
$502K Buy
35,051
+13,052
+59% +$192K 0.02% 401
2021
Q4
$300K Sell
21,999
-1,957
-8% -$27.5K 0.01% 571
2021
Q3
$392K Buy
23,956
+4,907
+26% +$82.4K 0.01% 454
2021
Q2
$321K Buy
19,049
+951
+5% +$16.2K 0.01% 500
2021
Q1
$330K Buy
18,098
+2,018
+13% +$36.3K 0.01% 421
2020
Q4
$293K Buy
16,080
+1,382
+9% +$24.2K 0.01% 417
2020
Q3
$262K Buy
14,698
+951
+7% +$17.3K 0.01% 386
2020
Q2
$246K Buy
13,747
+778
+6% +$14K 0.01% 383
2020
Q1
$197K Sell
12,969
-4,567
-26% -$82.8K 0.02% 417
2019
Q4
$346K Buy
17,536
+3,351
+24% +$64.1K 0.03% 321
2019
Q3
$244K Buy
14,185
+6,810
+92% +$118K 0.02% 358
2019
Q2
$131K Sell
7,375
-5,831
-44% -$106K 0.01% 528
2019
Q1
$269K Buy
13,206
+12,676
+2,392% +$255K 0.02% 296
2018
Q4
$9K Buy
+530
New +$8.95K ﹤0.01% 1395

Other funds holding TAK